Patients with type 2 diabetes For patients using GLP-1 medications for both weight loss and glycemic control, treatment duration extends to address both conditions
Although DPP4 inhibitors potentiate the intestinotrophic actions of coadministered native GLP-2, administration of DPP4 inhibitors alone has little or no consequence for the intestinal actions of native endogenous GLP-2 in vivo (88)
33 , 781790.e5 (2021)
Upon binding to GLP-1 R on pancreatic -cells, GLP-1 activates a G-protein complex, resulting in the release of the Gs subunit
Moreover, individuals who are malnourished, have cancer, are elderly, pregnant, or are alcoholics are also at higher risk in suffering the lack of vitamin B12
Some people may notice a positive effect on their weight loss when taking both medications, while others may not see much difference